IMP dehydrogenase basal activity in MOLT‐4 human leukaemia cells is altered by mycophenolic acid and 6‐thioguanosine

References

• Carr S. F., Papp E., Wu J. C., Natsumeda Y. Characterization of human type I and type II IMP dehydrogenases. J Biol Chem 1993; 268: 27286–90
   PubMed Web of Science ®Google Scholar
• Franklin T. J., Cook J. M. The inhibition of nucleic acid synthesis by mycophenolic acid. Biochem J 1969; 113: 515–24
   PubMed Web of Science ®Google Scholar
• Hager P. W., Collart F. R., Huberman E., Mitchell B. S. Recombinant human inosine monophosphate dehydrogenase type I and type II proteins. Purification and characterization of inhibitor binding. Biochem Pharmacol 1995; 49: 1323–9
   PubMedGoogle Scholar
• Tidd D. M., Paterson A. R. A biochemical mechanism for the delayed cytotoxic reaction of 6‐mercaptopurine. Cancer Res 1974; 34: 738–46
   PubMed Web of Science ®Google Scholar
• Natsumeda Y., Ohno S., Kawasaki H., Konno Y., Weber G., Suzuki K. Two distinct cDNAs for human IMP dehydrogenase. J Biol Chem 1990; 265: 5292–5
   PubMed Web of Science ®Google Scholar
• Senda M., Natsumeda Y. Tissue‐differential expression of two distinct genes for human IMP dehydrogenase (E.C.1.1.1.205). Life Sci 1994; 54: 1917–26
   PubMed Web of Science ®Google Scholar
• Zimmermann A. G., Gu J. J., Laliberte J., Mitchell B. S. Inosine‐5'‐monophosphate dehydrogenase: regulation of expression and role in cellular proliferation and T lymphocyte activation. Prog Nucleic Acid Res Mol Biol 1998; 61: 181–209
   PubMed Web of Science ®Google Scholar
• Jain J., Almquist S. J., Ford P. J., Shlyakhter D., Wang Y., Nimmesgern E., et al. Regulation of inosine monophosphate dehydrogenase type I and type II isoforms in human lymphocytes. Biochem Pharmacol 2004; 67: 767–76
   PubMed Web of Science ®Google Scholar
• Glesne D. A., Collart F. R., Huberman E. Regulation of IMP dehydrogenase gene expression by its end products, guanine nucleotides. Mol Cell Biol 1991; 11: 5417–25
   PubMedGoogle Scholar
• Griesmacher A., Weigel G., Seebacher G., Muller M. M. IMP‐dehydrogenase inhibition in human lymphocytes and lymphoblasts by mycophenolic acid and mycophenolic acid glucuronide. Clin Chem 1997; 43: 2312–7
   PubMed Web of Science ®Google Scholar
• Stet E. H., De Abreu R. A., Bokkerink J. P., Lambooy L. H., Vogels‐Mentink T. M., Keizer‐Garritsen J. J., et al. Inhibition of IMP dehydrogenase by mycophenolic acid in Molt F4 human malignant lymphoblasts. Ann Clin Biochem 1994; 31 Pt 2: 174–80
   PubMedGoogle Scholar
• Vethe N. T., Bergan S. Determination of inosine monophosphate dehydrogenase activity in human CD4+ cells isolated from whole blood during mycophenolic acid therapy. Ther Drug Monit 2006; 28: 608–13
   PubMed Web of Science ®Google Scholar
• Bremer S., Rootwelt H., Bergan S. Real‐time PCR determination of IMPDH1 and IMPDH2 expression in blood cells. Clin Chem 2007; 53: 1023–9
   PubMedGoogle Scholar
• Jagodzinski P., Lizakowski S., Smolenski R. T., Slominska E. M., Goldsmith D., Simmonds H. A., et al. Mycophenolate mofetil treatment following renal transplantation decreases GTP concentrations in mononuclear leucocytes. Clin Sci (Lond) 2004; 107: 69–74
   PubMedGoogle Scholar
• Ruckemann K., Fairbanks L. D., Carrey E. A., Hawrylowicz C. M., Richards D. F., Kirschbaum B., et al. Leflunomide inhibits pyrimidine de novo synthesis in mitogen‐stimulated T‐lymphocytes from healthy humans. J Biol Chem 1998; 273: 21682–91
   PubMed Web of Science ®Google Scholar
• Weimert N. A., Derotte M., Alloway R. R., Woodle E. S., Vinks A. A. Monitoring of inosine monophosphate dehydrogenase activity as a biomarker for mycophenolic acid effect: potential clinical implications. Ther Drug Monit 2007; 29: 141–9
   PubMed Web of Science ®Google Scholar
• Brouwer C., Vermunt‐de Koning D. G., Trueworthy R. C., Ter Riet P. G., Duley J. A., Trijbels F. J., et al. Monitoring of inosine monophosphate dehydrogenase activity in mononuclear cells of children with acute lymphoblastic leukemia: enzymological and clinical aspects. Pediatr Blood Cancer 2006; 46: 434–8
   PubMed Web of Science ®Google Scholar
• Vora A., Mitchell C. D., Lennard L., Eden T. O., Kinsey S. E., Lilleyman J., et al. Toxicity and efficacy of 6‐thioguanine versus 6‐mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial. Lancet 2006; 368: 1339–48
   PubMed Web of Science ®Google Scholar
• Ji Y., Gu J., Makhov A. M., Griffith J. D., Mitchell B. S. Regulation of the interaction of inosine monophosphate dehydrogenase with mycophenolic acid by GTP. J Biol Chem 2005; 281: 206–12
   PubMedGoogle Scholar
• Allison A. C., Eugui E. M. Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection. Transplantation 2005; 80: S181–90
   PubMed Web of Science ®Google Scholar
• Daxecker H., Raab M., Cichna M., Markl P., Muller M. M. Determination of the effects of mycophenolic acid on the nucleotide pool of human peripheral blood mononuclear cells in vitro by high‐performance liquid chromatography. Clin Chim Acta 2001; 310: 81–7
   PubMedGoogle Scholar
• Qiu Y., Fairbanks L. D., Ruckermann K., Hawrlowicz C. M., Richards D. F., Kirschbaum B., et al. Mycophenolic acid‐induced GTP depletion also affects ATP and pyrimidine synthesis in mitogen‐stimulated primary human T‐lymphocytes. Transplantation 2000; 69: 890–7
   PubMedGoogle Scholar
• Devyatko E., Zuckermann A., Bohdjalian A., Roedler S., Dunkler D., Grimm M., et al. Activation of the purine salvage pathway in mononuclear cells of cardiac recipients treated with mycophenolate mofetil. Transplantation 2006; 82: 113–18
   PubMedGoogle Scholar
• Goldsmith D., Carrey E. A., Edbury S., Smolenski R. T., Jagodzinski P., Simmonds H. A. Mycophenolate mofetil, an inhibitor of inosine monophosphate dehydrogenase, causes a paradoxical elevation of GTP in erythrocytes of renal transplant patients. Clin Sci (Lond) 2004; 107: 63–8
   PubMedGoogle Scholar
• Weigel G., Griesmacher A., Zuckermann A. O., Laufer G., Mueller M. M. Effect of mycophenolate mofetil therapy on inosine monophosphate dehydrogenase induction in red blood cells of heart transplant recipients. Clin Pharmacol Ther 2001; 69: 137–44
   PubMed Web of Science ®Google Scholar